These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17083155)

  • 1. Abbott expands low cost Kaletra.
    AIDS Patient Care STDS; 2006 Oct; 20(10):731-2. PubMed ID: 17083155
    [No Abstract]   [Full Text] [Related]  

  • 2. Abbott agrees to expand access to Kaletra/Aluvia.
    AIDS Patient Care STDS; 2007 May; 21(5):366. PubMed ID: 17518529
    [No Abstract]   [Full Text] [Related]  

  • 3. Kaletra (ABT-378/r) approved.
    James JS
    AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to drugs: the case of Abbott in Thailand.
    Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S
    Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589
    [No Abstract]   [Full Text] [Related]  

  • 5. [When Doctors Without Borders writes to Miles White, chairman of Abbott Laboratories].
    Nau JY
    Rev Med Suisse; 2006 Mar; 2(59):882. PubMed ID: 16646375
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluvia tablet approved in 19 African countries.
    AIDS Patient Care STDS; 2007 Aug; 21(8):604-5. PubMed ID: 17902244
    [No Abstract]   [Full Text] [Related]  

  • 7. Kaletra (ABT-378/r) application for accelerated approval.
    AIDS Treat News; 2000 Jun; (345):2-3. PubMed ID: 12170977
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 9. The state of access to Kaletra.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):4-5. PubMed ID: 17228448
    [No Abstract]   [Full Text] [Related]  

  • 10. Abbott Laboratories increases Norvir price fivefold.
    James JS
    AIDS Treat News; 2003 Dec; (397):3-5. PubMed ID: 14989182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norvir hangover.
    Clifton CE
    Posit Aware; 2004; 15(2):7-9. PubMed ID: 15106524
    [No Abstract]   [Full Text] [Related]  

  • 12. Backlash over ritonavir price hike.
    Huff B
    BETA; 2004; 16(4):15-7. PubMed ID: 15386839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug pricing. HIV/AIDS patients file federal antitrust suit against Abbott.
    AIDS Policy Law; 2004 May; 19(9):9. PubMed ID: 15202406
    [No Abstract]   [Full Text] [Related]  

  • 14. Abbott announces RTV price concessions.
    Alcorn K
    IAPAC Mon; 2004 Mar; 10(3):77. PubMed ID: 15108678
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving access to second-line antiretrovirals.
    The Lancet
    Lancet; 2007 Apr; 369(9570):1320. PubMed ID: 17448798
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. Abbott sends out provider letter about Kaletra for kids.
    AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug pricing. AHF sues Abbott over drug price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981
    [No Abstract]   [Full Text] [Related]  

  • 18. Abbott Laboratories' pricing malfunction.
    Salyer D
    Surviv News (Atlanta Ga); 2004; 15(3):18-9. PubMed ID: 15218860
    [No Abstract]   [Full Text] [Related]  

  • 19. Pricing. Pharmacies file Norvir suits against Abbott.
    AIDS Policy Law; 2007 Nov; 22(21):9. PubMed ID: 18225373
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA issues warning letter to Abbott over Norvir pricing spin.
    GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.